Commonwealth Equity Services, LLC Avadel Pharmaceuticals PLC Transaction History

Commonwealth Equity Services, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$12.55 - $17.22 $512,981 - $703,867	-40,875 Reduced 50.98%	39,307 $664,000
Q4 2023 Feb 06, 2024	BUY	$9.64 - $14.59 $9,341 - $14,137	969 Added 1.22%	80,182 $1.13 Million
Q3 2023 Oct 23, 2023	BUY	$10.3 - $15.99 $26,038 - $40,422	2,528 Added 3.3%	79,213 $816,000
Q2 2023 Aug 10, 2023	BUY	$8.48 - $16.48 $272,632 - $529,832	32,150 Added 72.19%	76,685 $1.26 Million
Q1 2023 May 11, 2023	BUY	$6.41 - $9.95 $25,024 - $38,844	3,904 Added 9.61%	44,535 $407,000
Q4 2022 Feb 07, 2023	BUY	$5.02 - $10.0 $39,868 - $79,420	7,942 Added 24.3%	40,631 $290,000
Q3 2022 Nov 14, 2022	BUY	$2.57 - $7.31 $43,690 - $124,270	17,000 Added 108.36%	32,689 $163,000
Q2 2022 Jul 19, 2022	SELL	$1.07 - $6.95 $478 - $3,106	-447 Reduced 2.77%	15,689 $38,000
Q1 2022 May 04, 2022	BUY	$5.46 - $8.29 $5,460 - $8,290	1,000 Added 6.61%	16,136 $110,000
Q4 2021 Jan 31, 2022	SELL	$7.34 - $11.18 $11,898 - $18,122	-1,621 Reduced 9.67%	15,136 $122,000
Q3 2021 Oct 29, 2021	SELL	$6.49 - $9.91 $13,758 - $21,009	-2,120 Reduced 11.23%	16,757 $164,000
Q2 2021 Aug 11, 2021	SELL	$6.73 - $9.05 $11,441 - $15,385	-1,700 Reduced 8.26%	18,877 $127,000
Q1 2021 May 04, 2021	BUY	$6.61 - $10.07 $43,956 - $66,965	6,650 Added 47.75%	20,577 $186,000
Q4 2020 Feb 11, 2021	SELL	$5.03 - $7.95 $4,275 - $6,757	-850 Reduced 5.75%	13,927 $93,000
Q3 2020 Nov 05, 2020	BUY	$5.02 - $8.98 $2,685 - $4,804	535 Added 3.76%	14,777 $74,000
Q2 2020 Aug 12, 2020	BUY	$7.25 - $11.75 $103,254 - $167,343	14,242 New	14,242 $115,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.